Skip to main content
. 2017 Jun 13;9(6):147. doi: 10.3390/v9060147

Figure 3.

Figure 3

Therapeutically administered VGCV prevents mortality and mitigates Ad6-induced morbidity in immunosuppressed Syrian hamsters. (A) Survival. Ad6-Vehicle v. Ad6-VGCV p = 0.0067 (Log rank); (B) Body weight changes. † Means for the Ad6-Vehicle group are shown only up to 6 days post challenge; after this point, the deaths would confound group means. The error bars show the standard error of the mean.